Evidence map›Paper›PMID 10514405›Full record

ArticleThe American journal of pathology1999

Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.

A Wakkach, S Poea, E Chastre, C Gespach, F Lecerf, S De La Porte, S Tzartos, A Coulombe, S Berrih-Aknin

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vaccines against myasthenia gravis.Expert opinion on biological therapy · 2005
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

A WakkachCNRS ESA 8078, Hôpital Marie Lannelongue, Le Plessis-Robinsin, France Hôpital St-Antoine, Paris, France.
S Poea
E Chastre
C Gespach
F Lecerf
S De La Porte
S Tzartos
A Coulombe
S Berrih-Aknin
Centre National de la Recherche Scientifique · FRInserm · FRPasteur Hellenic Institute · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The subset of myoid cells is a normal component of the thymic stroma. To characterize these cells, we immortalized stromal cells from human thymus by using a plasmid vector encoding the SV40 T oncogene. Among the eight cell lines obtained, one had myoid characteristics including desmin and troponin antigens. This new line was designated MITC (myoid immortalized thymic cells). These cells expressed both the fetal and adult forms of muscle acetylcholine receptor (AChR) at the mRNA level, as well as the myogenic transcription factor MyoD1. alpha-Subunit AChR protein expression was detected by flow cytometry and the AChR was functional in patch-clamp studies. In addition, AChR expression was down-modulated by myasthenia gravis sera or by monoclonal antibody anti-AChR on MITC line similarly to TE671 rhabdomyosarcoma cells, making the MITC line an interesting tool for AChR antigenic modulation experiments. Finally, the MITC line expressed LFA-3, produced several cytokines able to act on T cells, and protected total thymocytes from spontaneous apoptosis in vitro. These results are compatible with a role of thymic myoid cells in some steps of thymocyte development. Therefore MITC line appears to be a useful tool to investigate the physiological role of thymic myoid cells.

Indexed as

Antigenic ModulationAntigens, Viral, TumorApoptosisAutoantibodiesBlotting, NorthernCell LineChildCytokinesFlow CytometryHumansImmunophenotypingIn Vitro TechniquesMyasthenia GravisMyoD ProteinPatch-Clamp TechniquesReceptors, CholinergicAntigens, Viral, TumorAutoantibodiesCytokinesMyoD1 myogenic differentiation proteinMyoD ProteinReceptors, CholinergicRNA, Messenger

Identifiers

PMID10514405
PMCPMC1867031
OpenAlexW1529454591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.